Fluorescite (fluorescein injection)
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
February 2016
CONTRAINDICATIONS
Hypersensitivity
FLUORESCITE® Injection 10% is contraindicated in patients with known...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts
More News: Drugs & Pharmacology